NCT00991705已完成1 期
An Open-label, Two-treatment, Two-period, Two-sequence, Crossover Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
The purpose of this study is to evaluate the effect of atorvastatin on the pharmacokinetics of fimasartan.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •age: 20 - 45 years
- •sex: male
- •body weight: greater than 55 kg
- •written informed consent
排除标准
- •known allergy to Fimasartan and atorvastatin
- •existing cardiac or hematological diseases
- •existing hepatic and renal diseases
- •existing gastrointestinal diseases
- •acute or chronic diseases which could affect drug absorption or metabolism history of any serious psychological disorder
- •positive drug or alcohol screening
- •smokers of 10 or more cigarettes per day 3 month ago
- •participation in a clinical trial during the last 2 months prior to the start of the study
研究组 & 干预措施
Group B
Other
Atorvastatin (7 days) → Fimasartan + Atorvastatin (7 days)
干预措施: Atorvastatin (Drug)
Group B
Other
Atorvastatin (7 days) → Fimasartan + Atorvastatin (7 days)
干预措施: Fimasartan (Drug)
Group A
Other
Fimasartan (7 days) → Fimasartan + Atorvastatin (7 days)
干预措施: Atorvastatin (Drug)
Group A
Other
Fimasartan (7 days) → Fimasartan + Atorvastatin (7 days)
干预措施: Fimasartan (Drug)
研究者
相似试验
已完成
1 期
Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineEssential HypertensionHyperlipidemiaNCT01842230Chong Kun Dang Pharmaceutical24
已完成
1 期
CKD-337 Drug Interaction StudyDyslipidemia (Fredrickson Type Ⅱa)Dyslipidemia (Fredrickson Type Ⅱb)NCT02066207Chong Kun Dang Pharmaceutical30
撤回
1 期
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIAdvanced Adenocarcinoma of the Colon or RectumNCT01605344UNC Lineberger Comprehensive Cancer Center
进行中（未招募）
不适用
Study of atorvastatin and fenofibrate mediated effects on the metabolism and hepatic excretion of biliary compounds in gallstone patients.Gallstone diseaseMedDRA version: 8.1Level: LLTClassification code 10020667Term: HyperlipidemiaEUCTR2006-001972-19-SEHanns-Ulrich Marschall30
已完成
1 期
Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersHypertensionNCT02397590Boryung Pharmaceutical Co., Ltd36